Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 10.09
+0.22 (2.23%)
At close: Sep 30, 2026
Sinotherapeutics Revenue
Sinotherapeutics had revenue of 96.61M CNY in the quarter ending June 30, 2026, a decrease of -12.71%. This brings the company's revenue in the last twelve months to 418.12M, down -18.53% year-over-year. In the year 2025, Sinotherapeutics had annual revenue of 446.57M, down -12.71%.
Revenue (ttm)
418.12M
Revenue Growth
-18.53%
P/S Ratio
10.84
Revenue / Employee
1.31M
Employees
319
Market Cap
4.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 446.57M | -65.05M | -12.71% |
| Dec 31, 2024 | 511.62M | 211.75M | 70.61% |
| Dec 31, 2023 | 299.87M | 52.31M | 21.13% |
| Dec 31, 2022 | 247.56M | -67.91M | -21.53% |
| Dec 31, 2021 | 315.47M | -3.69M | -1.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.